Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Scientists probe strategies to repair neuron damage in multiple sclerosis.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
Multiple sclerosis disease-modifying therapy and pregnancy.
Sodium intake is associated with increased disease activity in multiple sclerosis.
Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia: Results from the National Cross-Sectional Study.
Evaluating Working Ability and Quality of Life of Patients with Multiple Sclerosis.
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Making Treatment & Lifestyle Decisions: Thinking About Benefits & Risks
The complex role of estrogens in inflammation.
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis.
Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis.
Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy.
Leptin and other adipokines in EAE and MS
Protective Effects of PGC-1α via the Mitochondrial Pathway in Rat Brains after Intracerebral Hemorrhage.
A timing-of-birth effect on multiple sclerosis clinical phenotype.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
MS research gears up for new drugs
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Improving the translational hit of experimental treatments in multiple sclerosis.
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands.
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.